| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $475.9M | +48.4% |
| Cost of Revenue | $87.0M | +37.1% |
| Gross Profit | $388.9M | +51.1% |
| R&D Expense | $195.4M | +18.4% |
| SG&A Expense | $135.0M | +20.4% |
| Operating Income | -$297.3M | -2.8% |
| Pre-tax Income | -$273.3M | +5.5% |
| Income Tax | $1.0M | +2.7% |
| Net Income | -$274.3M | +5.5% |
| EPS (Basic) | -$1.47 | +57.8% |
| EPS (Diluted) | -$1.47 | +57.8% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.29B | -5.1% |
| Accounts Receivable | $162.4M | +28.0% |
| Current Assets | $1.51B | -1.5% |
| Total Assets | $1.63B | +0.3% |
| Current Liabilities | $380.8M | +23.4% |
| Total Liabilities | $423.0M | +23.9% |
| Stockholders' Equity | $1.21B | -6.0% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$84.5M | -50.2% |
| Capital Expenditures | $252K | +17.8% |
| Investing Cash Flow | -$9.0M | -36.4% |
| Financing Cash Flow | $22.0M | -98.1% |
| Free Cash Flow | -$84.7M | -50.1% |